Tokyo Tape
Sign in
← Hisamitsu Pharmaceutical Co

Annual report

4530.TEDINET S100THNM
Period2023-03-01 → 2024-02-29
Filed2024-05-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 158
MetricValuePeriodScopeSource row
Revenue¥141.7bn2023-03-01 → 2024-02-29Cons.Net sales
Revenue¥128.3bn2022-03-01 → 2023-02-28Cons.Net sales
Revenue¥120.2bn2021-03-01 → 2022-02-28dCons.Net sales (5-year summary)
Revenue¥114.5bn2020-03-01 → 2021-02-28dCons.Net sales (5-year summary)
Revenue¥141.0bn2019-03-01 → 2020-02-29dCons.Net sales (5-year summary)
Operating income¥13.2bn2023-03-01 → 2024-02-29Cons.Operating income
Operating income¥11.6bn2022-03-01 → 2023-02-28Cons.Operating income
Ordinary income¥19.6bn2023-03-01 → 2024-02-29Cons.Ordinary income
Ordinary income¥16.1bn2022-03-01 → 2023-02-28Cons.Ordinary income
Ordinary income¥12.6bn2021-03-01 → 2022-02-28dCons.Ordinary income loss (5-year summary)
Ordinary income¥11.8bn2020-03-01 → 2021-02-28dCons.Ordinary income loss (5-year summary)
Ordinary income¥25.6bn2019-03-01 → 2020-02-29dCons.Ordinary income loss (5-year summary)
Profit before tax¥19.2bn2023-03-01 → 2024-02-29Cons.Income before income taxes
Profit before tax¥16.1bn2022-03-01 → 2023-02-28Cons.Income before income taxes
Net income (owners)¥14.0bn2023-03-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)¥11.7bn2022-03-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income (owners)¥9.7bn2021-03-01 → 2022-02-28dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥9.3bn2020-03-01 → 2021-02-28dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥18.7bn2019-03-01 → 2020-02-29dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥14.4bn2023-03-01 → 2024-02-29Cons.Profit loss
Net income¥12.1bn2022-03-01 → 2023-02-28Cons.Profit loss
Total assets¥328.8bnat 2024-02-29Cons.Assets
Total assets¥313.9bnat 2023-02-28Cons.Assets
Total assets¥302.9bnat 2022-02-28dCons.Total assets (5-year summary)
Total assets¥299.9bnat 2021-02-28dCons.Total assets (5-year summary)
Total assets¥307.4bnat 2020-02-29dCons.Total assets (5-year summary)
Total liabilities¥61.7bnat 2024-02-29Cons.Liabilities
Total liabilities¥55.5bnat 2023-02-28Cons.Liabilities
Net assets / equity¥267.1bnat 2024-02-29Cons.Net assets
Net assets / equity¥258.4bnat 2023-02-28Cons.Net assets
Net assets / equity¥254.9bnat 2022-02-28dCons.Net assets
Net assets / equity¥253.8bnat 2021-02-28dCons.Net assets (5-year summary)
Net assets / equity¥250.7bnat 2020-02-29dCons.Net assets (5-year summary)
Cash and deposits¥112.5bnat 2024-02-29Cons.Cash and deposits
Cash and deposits¥122.2bnat 2023-02-28Cons.Cash and deposits
Cash & equivalents¥66.4bnat 2024-02-29Cons.Cash and cash equivalents
Cash & equivalents¥65.4bnat 2023-02-28Cons.Cash and cash equivalents
Cash & equivalents¥86.2bnat 2022-02-28dCons.Cash and cash equivalents
Cash & equivalents¥91.4bnat 2021-02-28dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥87.0bnat 2020-02-29dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥18.2bn2023-03-01 → 2024-02-29Cons.Net cash provided by used in operating activities
Operating cash flow¥12.7bn2022-03-01 → 2023-02-28Cons.Net cash provided by used in operating activities
Operating cash flow¥19.2bn2021-03-01 → 2022-02-28dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥5.3bn2020-03-01 → 2021-02-28dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥27.4bn2019-03-01 → 2020-02-29dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥2.5bn2023-03-01 → 2024-02-29Cons.Net cash provided by used in investment activities
Investing cash flow−¥23.9bn2022-03-01 → 2023-02-28Cons.Net cash provided by used in investment activities
Investing cash flow−¥13.1bn2021-03-01 → 2022-02-28dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥7.8bn2020-03-01 → 2021-02-28dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥17.2bn2019-03-01 → 2020-02-29dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥16.7bn2023-03-01 → 2024-02-29Cons.Net cash provided by used in financing activities
Financing cash flow−¥14.7bn2022-03-01 → 2023-02-28Cons.Net cash provided by used in financing activities
Financing cash flow−¥15.2bn2021-03-01 → 2022-02-28dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥7.2bn2020-03-01 → 2021-02-28dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥11.7bn2019-03-01 → 2020-02-29dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥181.622023-03-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥148.012022-03-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥118.922021-03-01 → 2022-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥113.222020-03-01 → 2021-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥227.582019-03-01 → 2020-02-29dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥181.422023-03-01 → 2024-02-29Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥147.882022-03-01 → 2023-02-28Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥118.842021-03-01 → 2022-02-28dCons.Diluted earnings per share (5-year summary)
EPS (diluted)¥113.112020-03-01 → 2021-02-28dCons.Diluted earnings per share (5-year summary)
EPS (diluted)¥227.32019-03-01 → 2020-02-29dCons.Diluted earnings per share (5-year summary)
Net assets per share¥3,492.62at 2024-02-29Cons.Net assets per share (5-year summary)
Net assets per share¥3,294.2at 2023-02-28Cons.Net assets per share (5-year summary)
Net assets per share¥3,171.83at 2022-02-28dCons.Net assets per share (5-year summary)
Net assets per share¥3,083.98at 2021-02-28dCons.Net assets per share (5-year summary)
Net assets per share¥3,046.45at 2020-02-29dCons.Net assets per share (5-year summary)
Equity ratio80.5%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio81.6%at 2023-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio83.5%at 2022-02-28dCons.Equity to asset ratio (5-year summary)
Equity ratio84.1%at 2021-02-28dCons.Equity to asset ratio (5-year summary)
Equity ratio80.9%at 2020-02-29dCons.Equity to asset ratio (5-year summary)
ROE5.4%2023-03-01 → 2024-02-29Cons.Rate of return on equity (5-year summary)
ROE4.7%2022-03-01 → 2023-02-28Cons.Rate of return on equity (5-year summary)
ROE3.8%2021-03-01 → 2022-02-28dCons.Rate of return on equity (5-year summary)
ROE3.7%2020-03-01 → 2021-02-28dCons.Rate of return on equity (5-year summary)
ROE7.5%2019-03-01 → 2020-02-29dCons.Rate of return on equity (5-year summary)
Employees2,759at 2024-02-29Cons.Number of employees
Employees2,769at 2023-02-28Cons.Number of employees
Employees2,784at 2022-02-28dCons.Number of employees
Employees2,770at 2021-02-28dCons.Number of employees
Employees2,745at 2020-02-29dCons.Number of employees
Revenue¥96.6bn2023-03-01 → 2024-02-29StandaloneNet sales
Revenue¥93.0bn2022-03-01 → 2023-02-28StandaloneNet sales
Revenue¥90.6bn2021-03-01 → 2022-02-28dStandaloneNet sales (5-year summary)
Revenue¥86.7bn2020-03-01 → 2021-02-28dStandaloneNet sales (5-year summary)
Revenue¥109.8bn2019-03-01 → 2020-02-29dStandaloneNet sales (5-year summary)
Operating income¥10.7bn2023-03-01 → 2024-02-29StandaloneOperating income
Operating income¥10.8bn2022-03-01 → 2023-02-28StandaloneOperating income
Ordinary income¥14.2bn2023-03-01 → 2024-02-29StandaloneOrdinary income
Ordinary income¥14.1bn2022-03-01 → 2023-02-28StandaloneOrdinary income
Ordinary income¥10.6bn2021-03-01 → 2022-02-28dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥10.4bn2020-03-01 → 2021-02-28dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥21.5bn2019-03-01 → 2020-02-29dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥13.8bn2023-03-01 → 2024-02-29StandaloneIncome before income taxes
Profit before tax¥14.2bn2022-03-01 → 2023-02-28StandaloneIncome before income taxes
Net income¥9.9bn2023-03-01 → 2024-02-29StandaloneProfit loss
Net income¥10.4bn2022-03-01 → 2023-02-28StandaloneProfit loss
Net income¥7.2bn2021-03-01 → 2022-02-28dStandaloneNet income loss (5-year summary)
Net income¥8.3bn2020-03-01 → 2021-02-28dStandaloneNet income loss (5-year summary)
Net income¥15.1bn2019-03-01 → 2020-02-29dStandaloneNet income loss (5-year summary)
Total assets¥256.0bnat 2024-02-29StandaloneAssets
Total assets¥254.0bnat 2023-02-28StandaloneAssets
Total assets¥254.3bnat 2022-02-28dStandaloneTotal assets (5-year summary)
Total assets¥264.1bnat 2021-02-28dStandaloneTotal assets (5-year summary)
Total assets¥266.1bnat 2020-02-29dStandaloneTotal assets (5-year summary)
Total liabilities¥43.2bnat 2024-02-29StandaloneLiabilities
Total liabilities¥39.5bnat 2023-02-28StandaloneLiabilities
Net assets / equity¥212.8bnat 2024-02-29StandaloneNet assets
Net assets / equity¥214.5bnat 2023-02-28StandaloneNet assets
Net assets / equity¥222.4bnat 2022-02-28dStandaloneNet assets
Net assets / equity¥231.2bnat 2021-02-28dStandaloneNet assets (5-year summary)
Net assets / equity¥225.6bnat 2020-02-29dStandaloneNet assets (5-year summary)
Cash and deposits¥52.0bnat 2024-02-29StandaloneCash and deposits
Cash and deposits¥68.6bnat 2023-02-28StandaloneCash and deposits
EPS (basic)¥128.082023-03-01 → 2024-02-29StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥131.212022-03-01 → 2023-02-28StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥88.252021-03-01 → 2022-02-28dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥102.072020-03-01 → 2021-02-28dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥183.452019-03-01 → 2020-02-29dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥127.932023-03-01 → 2024-02-29StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥131.12022-03-01 → 2023-02-28StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥88.192021-03-01 → 2022-02-28dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥101.972020-03-01 → 2021-02-28dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥183.232019-03-01 → 2020-02-29dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥852023-03-01 → 2024-02-29StandaloneDividend paid per share (5-year summary)
Dividend per share¥84.52022-03-01 → 2023-02-28StandaloneDividend paid per share (5-year summary)
Dividend per share¥842021-03-01 → 2022-02-28dStandaloneDividend paid per share (5-year summary)
Dividend per share¥83.52020-03-01 → 2021-02-28dStandaloneDividend paid per share (5-year summary)
Dividend per share¥832019-03-01 → 2020-02-29dStandaloneDividend paid per share (5-year summary)
Net assets per share¥2,804.37at 2024-02-29StandaloneNet assets per share (5-year summary)
Net assets per share¥2,754.67at 2023-02-28StandaloneNet assets per share (5-year summary)
Net assets per share¥2,784.39at 2022-02-28dStandaloneNet assets per share (5-year summary)
Net assets per share¥2,825.43at 2021-02-28dStandaloneNet assets per share (5-year summary)
Net assets per share¥2,755.32at 2020-02-29dStandaloneNet assets per share (5-year summary)
Equity ratio83.0%at 2024-02-29StandaloneEquity to asset ratio (5-year summary)
Equity ratio84.3%at 2023-02-28StandaloneEquity to asset ratio (5-year summary)
Equity ratio87.3%at 2022-02-28dStandaloneEquity to asset ratio (5-year summary)
Equity ratio87.5%at 2021-02-28dStandaloneEquity to asset ratio (5-year summary)
Equity ratio84.6%at 2020-02-29dStandaloneEquity to asset ratio (5-year summary)
ROE4.6%2023-03-01 → 2024-02-29StandaloneRate of return on equity (5-year summary)
ROE4.8%2022-03-01 → 2023-02-28StandaloneRate of return on equity (5-year summary)
ROE3.2%2021-03-01 → 2022-02-28dStandaloneRate of return on equity (5-year summary)
ROE3.7%2020-03-01 → 2021-02-28dStandaloneRate of return on equity (5-year summary)
ROE6.7%2019-03-01 → 2020-02-29dStandaloneRate of return on equity (5-year summary)
Shares issued85,164,895at 2024-02-29StandaloneTotal number of issued shares (5-year summary)
Shares issued85,164,895at 2023-02-28StandaloneTotal number of issued shares (5-year summary)
Shares issued85,164,895at 2022-02-28dStandaloneTotal number of issued shares (5-year summary)
Shares issued85,164,895at 2021-02-28dStandaloneTotal number of issued shares (5-year summary)
Shares issued85,164,895at 2020-02-29dStandaloneTotal number of issued shares (5-year summary)
Employees1,506at 2024-02-29StandaloneNumber of employees
Employees1,521at 2023-02-28StandaloneNumber of employees
Employees1,587at 2022-02-28dStandaloneNumber of employees
Employees1,583at 2021-02-28dStandaloneNumber of employees
Employees1,569at 2020-02-29dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 2
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2024-02-2958 pure
Pharmaceutical Businessreportable segmentemployeesat 2024-02-292701 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,978
ItemContextValueUnit
Depreciation expenses research and development expenses sgaCurrentYearDuration_NonConsolidatedMember316000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2024-05-24
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第122期(自　2023年３月１日　至　2024年２月29日)
Company name cover pageFilingDateInstant
Original text (Japanese)久光製薬株式会社
Company name in english cover pageFilingDateInstantHISAMITSU PHARMACEUTICAL CO.,INC.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　中　冨　一　榮
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)佐賀県鳥栖市田代大官町408番地
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)0942(83)2101(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)執行役員BU本部長　　舛　屋　泰　之
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都千代田区丸の内二丁目４番１号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03(5293)1700(代表)
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)執行役員経営企画本部長　　磯　部　雄　一
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE00944
Fund codeFilingDateInstant－
Security codeFilingDateInstant45300
Filer name in japaneseFilingDateInstant
Original text (Japanese)久光製薬株式会社
Filer name in englishFilingDateInstantHisamitsu Pharmaceutical Co.,Inc.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第三号様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstanttrue
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte
Current fiscal year start dateFilingDateInstant2023-03-01
Current period end dateFilingDateInstant2024-02-29
Type of current periodFilingDateInstantFY
Current fiscal year end dateFilingDateInstant2024-02-29
Previous fiscal year start dateFilingDateInstant2022-03-01
Comparative period end dateFilingDateInstant2023-02-28
Previous fiscal year end dateFilingDateInstant2023-02-28
Next fiscal year start dateFilingDateInstant－
End date of quarterly or semi annual period of next fiscal yearFilingDateInstant－
Amendment flagFilingDateInstantfalse
Identification of document subject to amendmentFilingDateInstant－
Report amendment flagFilingDateInstantfalse
Xbrl amendment flagFilingDateInstantfalse
Business results of group (text)FilingDateInstantText · Plus
Business results of reporting company (text)FilingDateInstantText · Plus
Company history (text)FilingDateInstantText · Plus
Description of business (text)FilingDateInstantText · Plus
Overview of affiliated entities (text)FilingDateInstantText · Plus
Information about employees (text)FilingDateInstantText · Plus
Business policy business environment issues to address etc (text)FilingDateInstantText · Plus
Disclosure of sustainability related financial information (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2023-02-28pass
balance sheet identityconsolidated 2024-02-29pass rounding
balance sheet identitynon_consolidated 2023-02-28pass
balance sheet identitynon_consolidated 2024-02-29pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-02-28pass
statement vs summary · net assetsconsolidated 2023-02-28pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net assetsnon_consolidated 2022-02-28pass
statement vs summary · net assetsnon_consolidated 2023-02-28pass
statement vs summary · net assetsnon_consolidated 2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2022-03-01/2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-03-01/2024-02-29pass
statement vs summary · operating cash flowconsolidated 2022-03-01/2023-02-28pass
statement vs summary · operating cash flowconsolidated 2023-03-01/2024-02-29pass
statement vs summary · revenueconsolidated 2022-03-01/2023-02-28pass
statement vs summary · revenueconsolidated 2023-03-01/2024-02-29pass
statement vs summary · revenuenon_consolidated 2022-03-01/2023-02-28pass
statement vs summary · revenuenon_consolidated 2023-03-01/2024-02-29pass
statement vs summary · total assetsconsolidated 2023-02-28pass
statement vs summary · total assetsconsolidated 2024-02-29pass
statement vs summary · total assetsnon_consolidated 2023-02-28pass
statement vs summary · total assetsnon_consolidated 2024-02-29pass